Your browser doesn't support javascript.
loading
Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy.
Zhou, Jing; Feng, Ji; Wu, Yong; Dai, Hui-Qi; Zhu, Guang-Zhi; Chen, Pan-Hong; Wang, Li-Ming; Lu, Guang; Liao, Xi-Wen; Lu, Pei-Zhi; Su, Wen-Jing; Hooi, Shing Chuan; Ye, Xin-Pin; Shen, Han-Ming; Peng, Tao; Lu, Guo-Dong.
Afiliación
  • Zhou J; Department of Physiology, School of Basic Medical Sciences, Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Feng J; Department of Physiology, National University of Singapore, Singapore, 117593, Singapore.
  • Wu Y; Department of Toxicology, School of Public Health, Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Dai HQ; Department of Toxicology, School of Public Health, Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Zhu GZ; Department of Physiology, National University of Singapore, Singapore, 117593, Singapore.
  • Chen PH; Department of Toxicology, School of Public Health, Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Wang LM; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Lu G; Department of Physiology, School of Basic Medical Sciences, Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Liao XW; Department of Physiology, National University of Singapore, Singapore, 117593, Singapore.
  • Lu PZ; Department of Physiology, National University of Singapore, Singapore, 117593, Singapore.
  • Su WJ; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Hooi SC; Department of Toxicology, School of Public Health, Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Ye XP; Department of Toxicology, School of Public Health, Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Shen HM; Department of Physiology, National University of Singapore, Singapore, 117593, Singapore.
  • Peng T; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, Guangxi Province, P. R. China.
  • Lu GD; Department of Physiology, National University of Singapore, Singapore, 117593, Singapore. hmshen@um.edu.mo.
Exp Mol Med ; 54(11): 2007-2021, 2022 11.
Article en En | MEDLINE | ID: mdl-36385558
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Límite: Humans Idioma: En Revista: Exp Mol Med Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Límite: Humans Idioma: En Revista: Exp Mol Med Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2022 Tipo del documento: Article